Sulochana S, Narayanan S, Paramasivan C N, Suganthi C, Narayanan P R
Tuberculosis Research Centre, Indian Council of Medical Research, Chennai, Tamil Nadu, India.
J Chemother. 2007 Apr;19(2):166-71. doi: 10.1179/joc.2007.19.2.166.
Clinical isolates of Mycobacterium tuberculosis (47 ofloxacin-susceptible and 71 ofloxacin-resistant) strains obtained from individual patients from various parts of India were analyzed for gyr A mutation in quinolone resistant determining region (QRDR). Most of the mutations were seen clustered in the codons 90, 94 and 95, which is a hot spot region of QRDR. The types of mutations were correlated with the in vitro susceptibility pattern of the strains to ofloxacin. The mutations: A90V was found coded for low-level resistance (MIC <or=16 microg/ml), D94A and D94V were coded for moderate level resistance (MIC 32-64 microg/ml) and S91P, D94G and D94N were coded for high level resistance (MIC >64 microg/ml) to ofloxacin. The resistance to fluoroquinolones was observed predominantly due to gyr A mutations. There were 2 highly resistant strains that did not show any mutations for gyr A, were further analyzed for gyr B mutations and were found negative for any mutations. However, there were two novel mutations, namely R68G and L109V, which were found in sensitive strain that did not code for any change in the susceptibility pattern and require further investigation.
对从印度各地的个体患者中分离出的结核分枝杆菌临床菌株(47株对氧氟沙星敏感,71株对氧氟沙星耐药)进行了喹诺酮耐药决定区(QRDR)中gyrA突变分析。大多数突变集中在密码子90、94和95处,这是QRDR的一个热点区域。突变类型与菌株对氧氟沙星的体外药敏模式相关。发现突变A90V编码低水平耐药(MIC≤16μg/ml),D94A和D94V编码中度耐药(MIC 32 - 64μg/ml),S91P、D94G和D94N编码对氧氟沙星的高水平耐药(MIC>64μg/ml)。对氟喹诺酮类药物的耐药主要是由于gyrA突变。有2株高耐药菌株未显示gyrA任何突变,进一步分析gyrB突变,发现无任何突变。然而,在敏感菌株中发现了两个新突变,即R68G和L109V,它们未编码药敏模式的任何变化,需要进一步研究。